Eli Lilly (LLY)

• Market cap: $878B
• 1 day: -2.02%
• 5 days: -3.52%
• 1 month: -3.68%
• 3 months: -2.68%
• 6 months: 35.21%
• Year to date: -8.99%
• 1 year: 5.76%
• 5 years: 375.19%
• 10 years: 1,239.59%
• Sector: Healthcare
• Industry: Drug Manufacturers - General

About: Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Employees: 50,000